Speech pathology services to children with cancer and nonmalignant hematological disorders

Olivia D Taylor1, Robert S Ware, Kelly A Weir

  • 1Royal Children's Hospital, Herston, Queensland, Australia. olivia_taylor@health.qld.gov.au

Insights

Speech pathology (SP) support is crucial for children with cancer and blood disorders. Swallowing and feeding issues were most common, particularly in those with CNS tumors or nonmalignant hematological disorders.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Speech-Language Pathology

Background:

  • Children with cancer and nonmalignant hematological disorders often need speech pathology (SP) services.
  • Limited data exists on the prevalence and severity of swallowing, feeding, and communication impairments in this pediatric population.

Purpose of the Study:

  • To determine the prevalence and severity of swallowing/feeding and communication impairments in children referred to SP.
  • To explore associations between these impairments, specific diagnoses (oncology/hematology), and service utilization.

Main Methods:

  • Retrospective chart review of 70 children referred to SP at the Queensland Children's Cancer Centre.
  • Analysis of swallowing/feeding and communication dysfunction, diagnostic groups, and service delivery metrics.

Main Results:

  • Swallowing/feeding disorders were the most frequent initial impairments (58.6%).
  • Children with central nervous system tumors and nonmalignant hematological disorders showed significantly higher feeding impairment rates.
  • Central nervous system tumors were associated with the highest rates of oral and pharyngeal dysphagia.

Conclusions:

  • Speech pathology intervention is vital for pediatric cancer and hematology patients, especially those with CNS tumors.
  • Further prospective research is needed to understand the long-term impact of cancer treatments on swallowing and communication functions.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...